Equities research analysts forecast that LHC Group (NASDAQ:LHCG) will announce earnings per share of $0.62 for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for LHC Group’s earnings. The highest EPS estimate is $0.63 and the lowest is $0.58. LHC Group posted earnings of $0.58 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 6.9%. The business is scheduled to announce its next earnings report on Wednesday, March 14th.
On average, analysts expect that LHC Group will report full year earnings of $2.40 per share for the current financial year, with EPS estimates ranging from $2.38 to $2.44. For the next year, analysts expect that the business will post earnings of $2.67 per share, with EPS estimates ranging from $2.52 to $2.78. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research analysts that follow LHC Group.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 EPS for the quarter, beating the consensus estimate of $0.60 by $0.04. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The business had revenue of $272.90 million during the quarter, compared to analyst estimates of $265.35 million. During the same quarter in the previous year, the business posted $0.54 EPS. The company’s quarterly revenue was up 18.2% compared to the same quarter last year.
LHC Group (NASDAQ LHCG) traded down $0.34 during trading hours on Friday, hitting $65.43. 352,819 shares of the stock traded hands, compared to its average volume of 255,733. LHC Group has a twelve month low of $41.66 and a twelve month high of $76.14. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. The company has a market cap of $1,202.21, a price-to-earnings ratio of 28.23, a P/E/G ratio of 1.95 and a beta of 0.69.
In related news, COO Donald Dwayne Stelly sold 2,650 shares of the firm’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the sale, the chief operating officer now directly owns 109,235 shares in the company, valued at $7,137,414.90. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 14.80% of the company’s stock.
A number of hedge funds have recently made changes to their positions in LHCG. Geode Capital Management LLC boosted its stake in LHC Group by 13.8% during the first quarter. Geode Capital Management LLC now owns 140,971 shares of the health services provider’s stock worth $7,598,000 after buying an additional 17,108 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in shares of LHC Group by 7.0% in the first quarter. Schwab Charles Investment Management Inc. now owns 84,338 shares of the health services provider’s stock valued at $4,546,000 after purchasing an additional 5,551 shares during the period. Bank of America Corp DE boosted its stake in shares of LHC Group by 123.5% in the first quarter. Bank of America Corp DE now owns 34,658 shares of the health services provider’s stock valued at $1,868,000 after purchasing an additional 19,154 shares during the period. State Street Corp boosted its stake in shares of LHC Group by 4.7% in the first quarter. State Street Corp now owns 391,375 shares of the health services provider’s stock valued at $21,095,000 after purchasing an additional 17,439 shares during the period. Finally, Capstone Asset Management Co. purchased a new position in shares of LHC Group in the second quarter valued at approximately $245,000. 85.25% of the stock is owned by institutional investors.
TRADEMARK VIOLATION NOTICE: This article was first posted by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.americanbankingnews.com/2017/12/02/zacks-brokerages-expect-lhc-group-lhcg-to-announce-0-62-earnings-per-share.html.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.